1 North Wealth Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2K Hold
50
﹤0.01% 295
2026
Q1
$1.4K Hold
50
﹤0.01% 252
2025
Q4
$1.25K Hold
50
﹤0.01% 264
2025
Q3
$1.27K Hold
50
﹤0.01% 243
2025
Q2
$1.21K Hold
50
﹤0.01% 246
2025
Q1
$1.27K Buy
+50
New +$1.31K ﹤0.01% 244
2019
Q4
$51K Buy
1,375
+513
+60% +$18.3K 0.03% 91
2019
Q3
$29K Buy
+862
New +$31.3K 0.02% 92
2019
Q1
$36K Sell
899
-62
-6% -$2.48K 0.03% 80
2018
Q4
$40K Buy
+961
New +$39.9K 0.03% 76

Other funds holding PFE

1 North Wealth Services's PFE Position: Q2 2026 in Review

1 North Wealth Services held its Pfizer (PFE) position steady in Q2 2026 at 50 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #295.

1 North Wealth Services first reported a position in PFE in Q4 2018 and has held it in 10 quarters since. The position peaked at $51K in Q4 2019. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • 1 North Wealth Services held 50 shares of Pfizer worth $1.2K as of Q2 2026.
  • 1 North Wealth Services left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of 1 North Wealth Services's portfolio in Q2 2026, its #295 holding.
  • 1 North Wealth Services first reported a position in Pfizer in Q4 2018 and has held it in 10 quarters since.
  • 1 North Wealth Services's Pfizer position peaked at $51K in Q4 2019.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 1 North Wealth Services's 13F filing for Q2 2026, filed 3 Aug 2026.